A comparison of a new oral antifungal, terbinafine, with griseofulvin as therapy for tinea corporis.
暂无分享,去创建一个
[1] T. Jones,et al. Clinical efficacy and tolerability of terbinafine (Lamisil)—a new topical and systemic fungicidal drug for treatment of dermatomycoses , 1989, Clinical and experimental dermatology.
[2] R. Savin. Successful treatment of chronic tinea pedis (moccasin type) with terbinafine (Lamisil) , 1989, Clinical and experimental dermatology.
[3] N. Zaias,et al. The successful treatment of finger Trichophyton rubrum onychomycosis with oral terbinafine , 1989, Clinical and experimental dermatology.
[4] J. Jensen,et al. Clinical pharmacokinetics of terbinafine (Lamisil) , 1989, Clinical and experimental dermatology.
[5] G. Petrányi,et al. Antifungal activity of the allylamine derivative terbinafine in vitro , 1987, Antimicrobial Agents and Chemotherapy.
[6] A. Stutz,et al. Allylamines: topical and oral treatment of dermatomycoses with a new class of antifungal agents. , 1986, Acta dermato-venereologica. Supplementum.
[7] N. Ryder. Effect of allylamine antimycotic agents on fungal sterol biosynthesis measured by sterol side-chain methylation. , 1985, Journal of General Microbiology.
[8] N S Ryder,et al. Allylamine derivatives: new class of synthetic antifungal agents inhibiting fungal squalene epoxidase. , 1984, Science.